Wolfgang Renner: Immunostimulatory Nanoparticles for the Treatment of Allergic Asthma: Results from a Placebo-controlled Phase II Study (2011)

Allergen-free therapies for chronic allergic conditions such as
rhinoconjunctivitis and asthma are under development. Wolfgang
Renner explains how he hopes to eliminate the cause of allergic
asthmatic inflammation, thus offering patients an alternative to
replace or complement commonly used medications, while maintaining
or even improving asthma control.